Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
309 participants
OBSERVATIONAL
2009-12-31
2012-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Instanyl should be prescribed in accordance with the Summary of Product Characteristics (SPC) and none of the stated contradictions applies
* The decision to prescribe should be made independently of the study
* All patients must provide signed Informed Consent prior to inclusion
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Takeda
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nycomed Clinical Trial Operations
Role: STUDY_CHAIR
Headquarters
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Investigational site
Copenhagen, , Denmark
Investigational site
Herning, , Denmark
Investigational site
Hillerød, , Denmark
Investigational site
Randers, , Denmark
Investigational site
Aix-en-Provence, , France
Investigational site
Amiens, , France
Investigational site
Argenteuil, , France
Investigational site
Auxerre, , France
Investigational site
Besançon, , France
Investigational site
Blois, , France
Investigational site
Bobigny, , France
Investigational site
Bordeaux, , France
Investigational site
Brest, , France
Investigational site
Colmar, , France
Investigational site
Eaubonne, , France
Investigational site
Frelinghien, , France
Investigational site
Grenoble, , France
Investigational site
Lisieux, , France
Investigational site
Lorient, , France
Investigational site
Lyon, , France
Investigational site
Montbéliard, , France
Investigational site
Mulhouse, , France
Investigational site
Nancy, , France
Investigational site
Nantes, , France
Investigational site
Orléans, , France
Investigational site
Paris, , France
Investigational site
Paris, , France
Investigational site
Paris, , France
Investigational site
Pierre-Bénite, , France
Investigational site
Pontoise, , France
Investigational site
Saint-Herblain, , France
Investigational site
Strasbourg, , France
Investigational site
Strasbourg, , France
Investigational site
Tarbes, , France
Investigational site
Toulouse, , France
Investigational site
Vandœuvre-lès-Nancy, , France
Investigational site
Athens, , Greece
Investigational site
Athens, , Greece
Investigational site
Cork, , Ireland
Investigational site
Kilkenny, , Ireland
Investigational site
Bergen, , Norway
Investigational site
Bergen, , Norway
Investigational site
Bodø, , Norway
Investigational site
Fredrikstad, , Norway
Investigational site
Haugesund, , Norway
Investigational site
Kristiansand, , Norway
Investigational site
Lørenskog, , Norway
Investigational site
Oslo, , Norway
Investigational site
Oslo, , Norway
Investigational site
Oslo, , Norway
Investigational site
Stavanger, , Norway
Investigational site
Tromsø, , Norway
Investigational site
Alingsås, , Sweden
Investigational site
Stockholm, , Sweden
Investigational site
Sundsvall, , Sweden
Investigational site
Täby, , Sweden
Investigational site
Uppsala, , Sweden
Investigational site
Västervik, , Sweden
Investigational site
Belfast, , United Kingdom
Investigational site
Lanarkshire, , United Kingdom
Investigational site
Luton, , United Kingdom
Investigational site
Manchester, , United Kingdom
Investigational site
Middlesex, , United Kingdom
Investigational site
Suffolk, , United Kingdom
Investigational site
Wiltshire, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
U1111-1136-4251
Identifier Type: REGISTRY
Identifier Source: secondary_id
FT-1301-034-SP
Identifier Type: -
Identifier Source: org_study_id